You are here

P&T News

May 22

Drug indicated for use prior to surgery to boost platelet counts
Novel drug is a first-in-class treatment that reduces migraine occurrence
Lucemyra indicated for up to 14 days as part of a long-term treatment plan
Agent can also be used perioperatively in some patients to reduce the need for transfusions
Incidence increased 61% over a 14-year period

May 15

First drug approved to treat MS in patients as young as 10 years old
Six states will also participate in the litigation
Drug used in combination with bortezomib, melphalan, and prednisone
Scientists find new molecular target for developing safer pain medications

May 8

Kymriah now indicated for relapsed or refractory diffuse large B cell lymphoma
This is the third indication granted for the co-administered drugs
Approval based on clinical studies and real-world evidence
Lowest, total-volume preparation bowel cleanser available in U.S.
Gemcitabine flush is cost-effective and potentially “practice-changing”

May 1

Express Scripts to offer Praluent at roughly 60% off list price
Placenta-based stem cell therapy treats bone marrow unable to produce enough blood cells
Agent being studied to combat vulvovaginal candidiasis
Treatment benefits certain patients with BRAF V600-mutant disease
Agent indicated for patients at risk for autosomal dominant polycystic kidney disease